We evaluated the association of body mass index (BMI) with migraine and migraine specifics in a cross-sectional study of 63 467 women aged Ն 45 years, of whom 12 613 (19.9%) reported any history of migraine and 9195 had active migraine. Compared with women without migraine and a BMI < 23 kg/m 2 , women with a BMI Ն 35 kg/m 2 had adjusted odds ratios (ORs) (95% confidence intervals) of 1.03 (0.95, 1.12) for any history of migraine. Findings were similar for active migraineurs. Women with a BMI of Ն 35 kg/m 2 had increased risk for low and high migraine frequency, with the highest estimate for women who reported daily migraine. Compared with women with the lowest associated risk (migraine frequency < 6 times/year; BMI between 27.0 and 29.9 kg/m 2 ), women with a BMI Ն 35 kg/m 2 had an OR of daily migraine of 3.11 (1.12, 8.67). Among the women with active migraine, a BMI Ն 35 kg/m 2 was associated with increased risk of phonophobia and photophobia and decreased risk of a unilateral pain characteristic and migraine aura. Our data confirm previous findings that the association between BMI with migraine is limited to migraine frequency and specific migraine features. ᮀ Migraine, overweight, obesity, women, epidemiology
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A link between obesity and migraine would be of importance because the increasing prevalence of obesity (1) (2) (3) 14) may lead to an increase in the prevalence, frequency and severity of migraine and A.C.W. and T.K. performed the statistical analyses. T.K. had full data access and takes full responsibility for the integrity of the data and the accuracy of the data analysis. doi:10.1111/j.1468-2982.2008.01716.x may be a potential target for prevention. Furthermore, such a link may increase the risk of comorbidities that have recently been associated with migraine, such as ischaemic stroke (15) (16) (17) and other ischaemic vascular events (18, 19) . We thus aimed to evaluate the association between BMI and migraine, migraine frequency and migraine-related features in > 65 000 female health professionals in the USA.
Methods

Study population
This was a cross-sectional study among participants in the Women's Health Study (WHS), which was a randomized trial designed to evaluate the risks and benefits of low-dose aspirin and vitamin E in the primary prevention of cardiovascular disease and cancer among 39 876 initially apparently healthy women aged Ն 45 years at study entry (1992) (1993) (1994) (1995) . The design and methods of the WHS have been described in detail previously (20) (21) (22) (23) ; all participants provided written informed consent, and the Institutional Review Board of Brigham and Women's Hospital, Boston, MA approved the procedures of the WHS. In brief, invitation letters were mailed to 1757 247 female health professionals, including registered nurses, licensed vocational nurses, physicians, veterinarians, pharmacists, dieticians, dentists, dental hygienists, speech/ hearing/language professionals, physical therapists and radiology technologists from 52 different states (and the District of Columbia and Commonwealth of Puerto Rico). Of those, 453 787 returned the baseline questionnaire and 194 659 indicated their willingness to participate. The 65 169 women who were eligible entered the run-in phase of the trial, in which compliance with placebos intake was evaluated over 12 weeks. A total of 39 876 female health professionals were finally randomized into the WHS (20) . For the purpose of this analysis, we included information on the 65 169 women who entered the run-in phase of the trial. A total of 1464 women with missing information on BMI and 238 with missing information on migraine were excluded, leaving 63 467 participants for this analysis.
Assessment of migraine
Participants were asked on the baseline questionnaire: 'Have you ever had migraine headaches?' and 'In the past year, have you had migraine headaches?'. From this information, we categorized women into 'no history of migraine' and 'any history of migraine'. Furthermore, we distinguished between 'active migraine', which includes women with self-reported migraine in the year prior to completing the baseline questionnaire, and 'prior migraine', which includes women who reported ever having had a migraine but none in the year prior to completing the questionnaire. Those participants who reported active migraine were asked for further details about their migraine attacks, including attack duration of 4-72 h; unilateral location of pain; pulsating quality; inhibition of daily activities; aggravation by routine physical activity; nausea or vomiting; sensitivity to light; and sensitivity to sound. Furthermore, participants with active migraine were asked whether they had an aura or any indication a migraine is coming and the frequency of their migraine (daily, weekly, monthly, every other month, < 6 times/year). In previous studies of the WHS (18, 24, 25) , we have shown good agreement with modified 1988 International Headache Society (IHS) criteria for migraine in the WHS (26) . Specifically, we showed that among WHS participants who reported active migraine, 83.5% fulfilled all but one IHS criteria (code 1.7, migrainous disorder), and 46.6% fulfilled all IHS criteria for migraine (code 1.1 migraine without aura) (18) .
Body mass index
Participants were asked to report their height and weight on the baseline questionnaire. Based on this information, BMI, defined as weight in kilograms divided by height in meters squared (kg/m 2 ), was calculated. We categorized BMI values into six categories: < 23.0, 23.0-24.9, 25.0-26.9, 27.0-29.9, 30.0-34.9 and Ն 35.0 kg/m 2 . Further dividing the leanest group into additional categories did not indicate different associations. Self-reported and directly measured weight were highly correlated (r = 0.96) in another comparable cohort of female health professionals (27) .
Statistical methods
We compared baseline characteristics of participants with respect to BMI categories using analysis of variance for continuous variables and Mantel-Haenszel test for categorical variables. We used age-and multivariable-adjusted multinominal logistic regression models to evaluate the association between BMI categories and migraine status using women with a BMI of < 23 kg/m 2 and who had no history of migraine as the reference group. Multinominal logistic regression models were further used to evaluate the association between BMI categories and migraine frequencies among women who reported active migraine using women with a BMI of < 23 kg/m 2 and with a migraine frequency of < 6 times/year as the reference group. To evaluate further the shape of the BMI-migraine frequency association, we also used the group with the lowest associated risk (migraine frequency < 6 times/year and BMI between 27.0 and 29.9 kg/m 2 ) as reference group. To evaluate the association between BMI and migraine-related features in the subgroup of participants who indicated active migraine, multivariable-adjusted unconditional logistic regression models were used. The following migraine features were evaluated: aura, sensitivity to sound, sensitivity to light, nausea/vomiting, pulsating pain, inhibition of daily activities, aggravation by routine physical activity, and unilateral pain. We calculated prevalence odds ratios (ORs) and 95% confidence intervals (CIs) for the association between BMI categories and the various migraine outcomes.
The multivariable models were adjusted for age (continuous), smoking (never, past, current < 15 cigarettes/day, Ն 15 cigarettes/day), exercise (never/rarely, < 1 week, 1-3 times per week, Ն 4 times per week), alcohol consumption (never, < 1/week, weekly, and daily), history of hypertension, postmenopausal status, postmenopausal hormone use (never, past, current) and history of elevated cholesterol (Ն 240 mg/dl or use of cholesterol-lowering medication).
We incorporated a missing value indicator if the number of women with missing information on covariates was > 300 or imputed a value otherwise. For all analyses, we used SAS (version 9.1; SAS Institute Inc., Cary, NC, USA); all P-values were two-tailed and P < 0.05 was considered to be statistically significant.
Results
Of the 63 467 participants, a total of 12 613 (19.9%) reported any history of migraine, of whom 9195 reported active migraine (migraine during the year prior to the baseline questionnaire). The mean BMI was 26.3 for women without a history of migraine and 26.6 for women with any history of migraine. Table 1 summarizes the comparison of the participants' baseline characteristics with respect to the BMI categories. Compared with women with a BMI of < 23 kg/m 2 , women with a BMI of Ն 35 kg/m 2 were younger, were more likely to have a history of migraine, to have a history of hypertension or diabetes, to currently smoke fewer cigarettes, to have a history of elevated cholesterol, to drink less alcohol and were less likely to use postmenopausal hormones and to exercise. Table 2 summarizes the association between BMI and migraine status. After adjustment for age and compared with women without a history of migraine and with a BMI of < 23.0 kg/m 2 , increasing BMI was associated with increased risk of any history of migraine. Women with a BMI between 30.0 and 34.9 kg/m 2 had an OR of any migraine history of 1.11 (95% CI 1.04, 1.19) that further increased to an OR of 1.21 (95% CI 1.12, 1.32) for women with a BMI Ն 35.0 kg/m 2 . The effect estimates were very similar when we made a distinction between active migraine and prior migraine. The association between BMI and migraine, however, entirely disappeared after controlling for smoking, exercise, alcohol consumption, history of hypertension, postmenopausal status, postmenopausal hormone intake and history of elevated cholesterol levels. Compared with women without migraine and a BMI < 23 kg/m 2 , women with migraine and a BMI of Ն 35.0 kg/m 2 had a multivariable-adjusted OR of 1.03 (95% CI 0.95, 1.12). Similarly, there was no association between BMI and active migraine or prior migraine (history of migraine but no indication of migraine in the 1 year prior to the baseline questionnaire).
With regard to the association between BMI and migraine frequency, we found a J-shaped pattern. Among women with active migraine and compared with women with a BMI < 23 kg/m 2 and a migraine frequency of < 6 times/year, the multivariableadjusted ORs (95% CI) for women with BMI Ն 35 kg/m 2 were 0.58 (0.42, 0.80) for a migraine frequency of every other month, 0.60 (0.48, 0.76) for a monthly migraine frequency, 0.59 (0.39, 0.87) for a weekly migraine frequency and 1.46 (0.63, 3.37) for a daily migraine frequency (Table 3 ). Using the BMI category with the lowest associated risk as the reference group (BMI between 27.0 and 29.9), emerged the J-shaped association between BMI and a daily migraine frequency ( Fig. 1) , with the highest risk estimate for the high-frequency group (OR 3.11, 95% CI 1.12, 8.67). Table 4 summarizes the association between BMI and migraine-related features among the women who reported active migraine at baseline. An increasing BMI was associated with an increased risk of sensitivity to sound as well as sensitivity to light that remained when adjusting for potential confounders. Among women with active migraine and compared with women with a BMI of < 23 kg/ m 2 , women with a BMI Ն 35 kg/m 2 had a multivariable-adjusted OR for sensitivity to sound of 1.42 (95% CI 1.19, 1.70) and an OR of sensitivity to light of 1.39 (95% CI 1.14, 1.68), with both significant trends across BMI categories. In addition, there was a suggestion of a trend that increasing BMI is associated with pulsating pain character (P trend = 0.05) and nausea/vomiting (P trend = 0.07), but the risk estimates in the highest BMI category were only slightly increased. On the other hand, a BMI of Ն 35 kg/m 2 was associated with a decreased risk of reporting a migraine aura (adjusted OR 0.82, 95% CI 0.68, 0.98; P trend = 0.11) and having unilateral pain (OR 0.81, 95% CI 0.68, 0.97; P trend = 0.001).
Discussion
In this large cohort of apparently healthy women, the age-adjusted small increased risk of migraine associated with high BMI values diminished after controlling for potential confounders. We found a J-shaped association between BMI and migraine frequency, indicating that women with a BMI of < 23 kg/m 2 and a BMI of Ն 35 kg/m 2 were at increased risk for having a daily migraine, with highest estimates for the high BMI category. Among women with active migraine, we found that increasing BMI was significantly associated with sensitivity to sound and light. In contrast, a BMI of Ն 35 kg/m 2 was associated with a decreased reporting of migraine aura and a unilateral pain characteristic. Consistent with our data, several studies have found no association between BMI and migraine (7, 9, 19, 28) . For example, in a cross-sectional study of 30 215 participants, the adjusted OR for migraine was 0.9 (95% CI 0.6, 1.2) for participants with a BMI of Ն 35.0 kg/m 2 compared with participants with a BMI between 18.5 and 24.9 kg/m 2 (7) . In three other studies, no difference was found in mean BMI values of migraineurs and participants without migraine (9, 19, 28) . In contrast, one small study has suggested that patients referred for obesity surgery had a higher prevalence of migraine compared with subjects with a BMI of < 25.0 kg/m 2 (5) .
Our finding of a J-shaped association between BMI and a high frequency of migraine is consistent with a recent study of 18 989 migraine patients (11) . The relative risk for having a migraine frequency of 10-14 days/month was 1.44 (95% CI 0.98, 1.96) for migraineurs with a BMI < 18.5 kg/m 2 and 1.74 (95% CI 1.41, 1.93) for migraineurs with a BMI of Ն 35 kg/m 2 when compared with patients with migraine and a BMI between 18.5 and 24.9 kg/m 2 .
Other studies have shown increased relative risk estimates for increasing BMI levels. In cross-sectional study of 30 215 participants, obesity was associated with the number of reported headache days per month (7) . Among migraineurs with an attack frequency of 10-14 days/month, the ORs were 2.9 (95% CI 1.9, 4.4) for being obese (BMI 30.0-34.9 kg/m 2 ) and 5.7 (95% CI 3.6, 8.8) for being morbidly obese (BMI Ն 35.0 kg/m 2 ). In contrast, a recent study from Sweden that included 684 women who participated in a mammogram screening programme did not find any association between BMI and migraine frequency, severity and duration (9) .
Two studies have indicated an association between obesity and chronic daily headache (CDH), which is defined as headaches occurring on Ն 15 days/month. In the first study of 1134 cases of patients with CDH and 798 controls, overweight and obesity were associated with CDH after adjusting for potential confounders (4) . Cases and controls were further followed for 11 months, during which time 23 incident cases of CDH occurred. After adjustment, obesity was associated with a fivefold increased risk of developing CDH (OR 5.28, 95% CI 1.3, 21.1) compared with participants with a BMI of < 25 kg/m 2 . The second study was a large population-based cross-sectional study, in which BMI was associated with CDH (8) . Compared with participants with a BMI between 18.5 and 24.9 kg/ m 2 , the OR of CDH was 2.0 (95% CI 1.4, 2.4) for participants with a BMI of Ն 35 kg/m 2 . Furthermore, the association between BMI and CDH was stronger for patients with transformed migraine compared with those with chronic tension-type headache.
Our data did not allow us to classify migraineurs as having CDH and no data on incident CDH were available.
As potential mechanisms for the observed association between BMI and increase in migraine frequency or CDH, inflammatory mediators, such as calcitonin gene-related peptide and interleukins, have been proposed that subsequently may influence migraine frequency and potentially cause central sensitization (12) . However, the J-shaped association between BMI and migraine frequency, as found in our data and in another large cohort study (11) , may suggest more complex mechanisms.
The only other study that evaluated the association between BMI and migraine features is the previously mentioned cross-sectional study (7) . Among the subgroup of patients with migraine (n = 3791), a BMI of Ն 35 kg/m 2 was associated with more severe headaches, worsened by physical activity, high disability, photophobia and phonophobia. In addition, women with a BMI of < 18.5 kg/m 2 had an increased risk of unilateral pain, although this finding was not statistically significant (OR 1.31, 95% CI 0.8, 1.2). Furthermore, in this study there was no association between BMI and migraine aura status. Our data confirm the association between high BMI levels and photo-as well as phonophobia and the inverse association between BMI and unilateral pain characteristic. In contrast, we found a modest inverse association with migraine aura status and we did not find associations between BMI and migraine-related inhibition of daily activities or migraine aggravation by physical activity. The nature of subgroup analyses as well as lack of clear biological mechanisms to explain the association between BMI and migraine-specific features, however, indicate caution in the interpretation of these findings.
The present study has several strengths, including the large number of participants and number of women with migraine as well as the standardized data ascertainment. In addition, we collected information about many migraine features, including migraine aura and migraine frequency.
Furthermore, information about a large number of potential confounders was available, allowing us to adjust the association between BMI and migraine. In addition, the homogeneous nature of WHS participants further reduced potential confounding.
Several limitations should be considered when interpreting our results. First, information on migraine, migraine frequency and migraine features was self-reported, and misclassification is possible. However, in previous studies using data from this cohort, good agreement between migraine classification and modified 1988 IHS criteria for migraine (26) were found (18, 24, 25) . In addition, our prevalence of migraine with aura is very close to that found in other population-based studies (29, 30) , in particular to the 37% figure reported in the American Migraine Study II (29) , although this study included participants who were Ն 12 years old. Furthermore, we cannot exclude the possibility that migraine status was underreported. However, we have no reason to believe that underreporting would depend on specific BMI categories and this is therefore an unlikely explanation of our findings. Second, information on body weight and height was also OR, odds ratio; CI, confidence interval. Odds ratios are calculated by using an unconditional logistic regression model with women with a body mass index of < 23 kg/m 2 as reference group.
*Adjusted for age, smoking, exercise, alcohol consumption, history of hypertension, postmenopausal status, postmenopausal hormone use and history of elevated cholesterol.
†P for linear trend.
self-reported. However, studies evaluating the validity of self-reported BMI have found excellent correlations (31) (32) (33) . Third, despite our ability to control for a large number of potential confounders, we cannot exclude the possibility of residual and unmeasurable confounding since our study is observational. Further, our data were crosssectional, not allowing us to determine the time sequence of the association between BMI and migraine. Lastly, the study population was limited to female health professionals aged Ն 45 years, the vast majority of whom were White. Thus, the present results may not necessarily be extrapolated to other female populations, and different associations between BMI and migraine as well as migraine-specific features in younger women and men cannot be excluded. In summary, the overwhelming evidence from epidemiological data does not support a causal relationship between BMI and occurrence of migraine. In contrast, we confirm previous findings of an association between BMI and migraine frequency and specific migraine features that warrant future investigations.
